NEW YORK, Oct. 8 /PRNewswire/ -- ExL Pharma, Cision and the PRSA have joined together to bring the pharmaceutical, medical device and biotech public relations executives the first Pharmaceutical Public Relations Symposium in conjunction with the PRSA 2007 International Conference. This one-day event will cover the key issues and challenges that these companies face in an industry that is under ongoing political and media scrutiny, most notably as we head into the 2008 election year.
The symposium offers perspectives from top pharmaceutical industry professionals representing companies such as: Pfizer, Wyeth, EMD-Serono, CCW Worldwide, Feinstein Kean Healthcare, Cision, ExL Pharma, and more. In addition, representatives from the FDA will speak on "Communicating More Effectively with the FDA" which will highlight key items on the FDA agenda in 2008. Topics of discussion will include enhancing corporate reputation, social responsibility, issues management, measurement of PR activities and merger or acquisition public relations strategies.
Bryon Main, Managing Director with ExL Pharma, had this to share about the upcoming event, "It is exciting to have partnered with PRSA and Cision to bring the pharmaceutical public relations professionals a one-day refresher symposium on top-of-mind issues for the industry as we head into 2008. This industry will be under even higher scrutiny in an election year and this event examines many key issues. We have a distinguished faculty ready to share ideas, as well as best practices, with attendees on how they can help improve the perception amongst key stakeholders."
The symposium is scheduled for October 23, 2007 at the Philadelphia Marriott hotel in downtown Philadelphia and is sponsored by PRSA Health Academy and CCW Worldwide. To view the full program agenda and/or to register, please visit http://www.exlpharma.com
*Please mention keycode EXLPHARMA<
|SOURCE ExL Pharma|
Copyright©2007 PR Newswire.
All rights reserved